News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
737,153 Results
Type
Article (49848)
Company Profile (278)
Press Release (687027)
Multimedia
Podcasts (63)
Webinars (12)
Section
Business (212341)
Career Advice (2098)
Deals (36539)
Drug Delivery (104)
Drug Development (83644)
Employer Resources (173)
FDA (16989)
Job Trends (15724)
News (359356)
Policy (34704)
Tag
Academia (2782)
Accelerated approval (5)
Adcomms (23)
Allergies (88)
Alliances (51622)
ALS (96)
Alzheimer's disease (1441)
Antibody-drug conjugate (ADC) (134)
Approvals (16988)
Artificial intelligence (280)
Autoimmune disease (23)
Automation (16)
Bankruptcy (373)
Best Places to Work (12096)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (191)
Bladder cancer (80)
Brain cancer (28)
Breast cancer (298)
Cancer (2351)
Cardiovascular disease (191)
Career advice (1762)
Career pathing (31)
CAR-T (155)
Cell therapy (437)
Cervical cancer (22)
Clinical research (67979)
Collaboration (875)
Company closure (1)
Compensation (558)
Complete response letters (21)
COVID-19 (2718)
CRISPR (43)
C-suite (261)
Cystic fibrosis (102)
Data (2304)
Decentralized trials (2)
Denatured (28)
Depression (51)
Diabetes (282)
Diagnostics (6588)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (122)
Drug pricing (107)
Drug shortages (28)
Duchenne muscular dystrophy (97)
Earnings (88961)
Editorial (40)
Employer branding (21)
Employer resources (147)
Events (117571)
Executive appointments (752)
FDA (18360)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (783)
Gene editing (114)
Generative AI (25)
Gene therapy (316)
GLP-1 (766)
Government (4692)
Grass and pollen (4)
Guidances (114)
Healthcare (19904)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (30)
Infectious disease (2869)
Inflammatory bowel disease (148)
Inflation Reduction Act (8)
Influenza (55)
Intellectual property (97)
Interviews (320)
IPO (16885)
IRA (41)
Job creations (4047)
Job search strategy (1501)
Kidney cancer (10)
Labor market (40)
Layoffs (489)
Leadership (18)
Legal (8466)
Liver cancer (79)
Lung cancer (331)
Lymphoma (157)
Machine learning (8)
Management (58)
Manufacturing (326)
MASH (73)
Medical device (14387)
Medtech (14392)
Mergers & acquisitions (20222)
Metabolic disorders (735)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (102)
Neuropsychiatric disorders (31)
Neuroscience (2012)
NextGen: Class of 2025 (6911)
Non-profit (4740)
Now hiring (40)
Obesity (393)
Opinion (218)
Ovarian cancer (78)
Pain (95)
Pancreatic cancer (89)
Parkinson's disease (154)
Partnered (21)
Patents (242)
Patient recruitment (117)
Peanut (48)
People (60197)
Pharmaceutical (68)
Pharmacy benefit managers (20)
Phase I (21151)
Phase II (29872)
Phase III (22316)
Pipeline (1296)
Policy (147)
Postmarket research (2741)
Preclinical (9036)
Press Release (67)
Prostate cancer (110)
Psychedelics (32)
Radiopharmaceuticals (256)
Rare diseases (393)
Real estate (6304)
Recruiting (65)
Regulatory (23741)
Reports (46)
Research institute (2482)
Resumes & cover letters (359)
Rett syndrome (5)
RNA editing (5)
RSV (44)
Schizophrenia (77)
Series A (131)
Series B (90)
Service/supplier (13)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3833)
State (2)
Stomach cancer (14)
Supply chain (71)
Tariffs (45)
The Weekly (33)
Vaccines (736)
Venture capitalists (42)
Weight loss (264)
Women's health (38)
Worklife (16)
Date
Today (267)
Last 7 days (861)
Last 30 days (2944)
Last 365 days (33445)
2025 (11589)
2024 (36109)
2023 (41146)
2022 (52382)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33747)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (794)
Alabama (54)
Alaska (7)
Arizona (240)
Arkansas (14)
Asia (41044)
Australia (6759)
California (6345)
Canada (2053)
China (550)
Colorado (281)
Connecticut (292)
Delaware (158)
Europe (88982)
Florida (938)
Georgia (216)
Idaho (61)
Illinois (586)
India (26)
Indiana (320)
Iowa (11)
Japan (170)
Kansas (107)
Kentucky (25)
Louisiana (12)
Maine (62)
Maryland (949)
Massachusetts (4776)
Michigan (230)
Minnesota (411)
Mississippi (2)
Missouri (83)
Montana (27)
Nebraska (25)
Nevada (67)
New Hampshire (68)
New Jersey (1794)
New Mexico (29)
New York (1801)
North Carolina (1051)
North Dakota (8)
Northern California (2777)
Ohio (210)
Oklahoma (14)
Oregon (35)
Pennsylvania (1414)
Puerto Rico (12)
Rhode Island (35)
South America (1186)
South Carolina (26)
South Dakota (1)
Southern California (2381)
Tennessee (105)
Texas (947)
United States (24124)
Utah (190)
Virginia (155)
Washington D.C. (68)
Washington State (578)
West Virginia (3)
Wisconsin (58)
737,153 Results for "illuminoss medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
IlluminOss Subsidiary ABL Medical Developing Anti-Microbial Blue Light Fiber Technology!
In 2018, IlluminOss Medical began offering a system in the US that used blue light delivered via a long fiber-optic catheter to harden light-curing liquid within balloon-like orthopedic implants.
February 9, 2024
·
2 min read
Genetown
IlluminOss Medical Breaks New Ground in Humerus Fracture Repair
IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, is addressing an unmet need in the burgeoning senior population.
November 13, 2023
·
3 min read
Business
IlluminOss Medical Appoints Craig Decker as Chief Executive Officer
July 10, 2024
·
2 min read
Genetown
Fall today, move tomorrow! Local news story highlights using IlluminOss to fix an older patient’s fracture to deliver fast rehabilitation instead of immobilization
IlluminOss Medical is announcing its patented, minimally-invasive technology for fracture repair in older patients was just featured on the Rhode Island Channel 10 News.
February 13, 2024
·
2 min read
Genetown
Curing with Light! IlluminOss Celebrates 10,000 Light-Cured Implants Used By Surgeons To Strengthen Fragile Bone And Heal Geriatric Fractures
IlluminOss Medical announces it has reached the important benchmark of having placed 10,000 of its patient conforming implants designed for the treatment of geriatric fractures.
January 24, 2024
·
2 min read
IlluminOss Receives 510K Clearance for a New Light Console for its Implants that Provide Strength for Fragile and Geriatric Bone
By combining years of clinical experience with cutting-edge research and development, IlluminOss Medical announces it has received FDA 510(k) clearance for a new Light-Emitting Diode (LED) Console to speed curing of its patented, light-cured implants.
January 31, 2024
·
2 min read
Press Releases
FDA Classifies Q’Apel Medical Inc.'s Worldwide Medical Device Recall and Discontinuation of its 072 Aspiration System (Hippo) as Class I
April 18, 2025
·
4 min read
Press Releases
Tenon Medical, Inc. Announces Timing of First Quarter 2025 Financial Results
April 29, 2025
·
2 min read
Press Releases
Transverse Medical Inc. Announces Completion of Series B2 Capital Raise
April 29, 2025
·
2 min read
Press Releases
Inspire Medical Systems, Inc. to Present at the BofA Securities 2025 Health Care Conference
April 30, 2025
·
1 min read
1 of 73,716
Next
